As an example, coating of PLGA particles with T cell specific antibodies or antibody F(ab’) fragments achieved targeted delivery of encapsulated immunomodulatory substances to CD4+ and CD8+ T cells ex vivo and in vivo in a murine tumor model [78,79,80]. The gene discussed is CD8A; the disease is neoplasm.